LII:NYSELennox International, Inc. Analysis
Data as of 2026-06-17 - not real-time
$528.33
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Lennox International is trading comfortably above its short‑term and medium‑term moving averages, with the MACD line perched above its signal line and a neutral‑zone RSI, suggesting modest bullish momentum. The recent dividend hike signals confidence in cash generation, while decreasing volume and a neutral trend direction hint at a short‑term consolidation phase.
Fundamentally, the company delivers solid revenue growth and strong profitability metrics, including a high return on equity and margins that outpace many peers. However, the DCF‑derived fair value sits well below the current market price and the stock’s beta and 30‑day volatility point to heightened price swings. With a PE multiple under the industry average but a price‑to‑book ratio that remains elevated, the equity appears stretched relative to intrinsic estimates, though the dividend payout remains modest and sustainable.
Fundamentally, the company delivers solid revenue growth and strong profitability metrics, including a high return on equity and margins that outpace many peers. However, the DCF‑derived fair value sits well below the current market price and the stock’s beta and 30‑day volatility point to heightened price swings. With a PE multiple under the industry average but a price‑to‑book ratio that remains elevated, the equity appears stretched relative to intrinsic estimates, though the dividend payout remains modest and sustainable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD but decreasing volume
- Price near short‑term resistance
- Neutral trend direction
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth and strong profitability
- Dividend increase with low payout ratio
- PE multiple below industry peers
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Durable demand for HVAC and building solutions
- Sustainable dividend backed by cash flow
- High return on equity indicating efficient capital use
Key Metrics & Analysis
Financial Health
Revenue Growth5.80%
Profit Margin15.09%
P/E Ratio23.3
ROE76.79%
ROA16.74%
Debt/Equity161.04
P/B Ratio15.2
Op. Cash Flow$809.5M
Free Cash Flow$187.1M
Industry P/E31.2
Technical Analysis
TrendNeutral
RSI57.4
Support$475.22
Resistance$542.19
MA 20$506.50
MA 50$505.17
MA 200$510.49
MACDBullish
VolumeDecreasing
Fear & Greed Index92.13
Valuation
Fair Value$36.25
Target Price$570.07
Upside/Downside7.90%
GradeOvervalued
TypeBlend
Dividend Yield1.04%
Risk Assessment
Beta1.26
Volatility35.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.